Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States
Get This Resource
English: Web Page
Summary
This document details recommendations updated in 2012 for HIV treatment of pregnant women and prophylaxis for perinatal HIV transmission in the United States. It provides health care providers with information to help HIV-1 infected pregnant women make informed decisions regarding the use of antiretroviral drugs during pregnancy and the use of elective cesarean delivery to reduce perinatal HIV transmission. Included in the report are a range of circumstances that commonly occur in clinical practice, highlighting individualized treatment considerations. Additionally, the focus has shifted towards clinical management of individual mother-child pairs in the antepartum, intrapartum and postpartum periods.
Related Resources
- Perinatal Antiretroviral Guidelines Slide Set
- Guidelines for Use of Antiretroviral Drugs in Pregnancy Card
- Tables on Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States
|
|
U.S. Department of Health and Human Services |
|
|
English |
|
|
Web Page |
|
|
United States of America |
|
|
Doctors/Physicians, Nurses |
|
|
Antiretroviral Treatment & Complications, Perinatal Interventions |
|
|
Clinical Guidelines |
